K Janatpour1, L Denning, K Nelson, B Betlach, M Mackenzie, P Holland. 1. Department of Pathology and Laboratory Medicine, University of California at Davis (UC Davis) Medical Center, Sacramento, CA 95817, USA. kim.janatpour@ucdmc.ucdavis.edu
Abstract
BACKGROUND AND OBJECTIVES: Transfusion-associated graft-versus-host disease (TA-GVHD) is a serious, potential complication of blood transfusion that is essentially prevented by blood product irradiation. Blood product irradiation is currently performed using gamma irradiation. X-ray irradiation is an alternative that has certain advantages: an X-ray irradiator is less expensive and does not have a radioactive source. However, the biochemical effects of X-ray irradiation on red blood cells (RBCs) have not been well characterized. The primary purpose of our study was to compare the effects of X-ray irradiation with gamma irradiation on RBC membrane permeability. A secondary purpose was to verify that X-ray irradiation has the same effect on lymphocytes as gamma irradiation. MATERIALS AND METHODS: Ten RBC units were split into two portions; five units of each were then irradiated with either gamma or X-ray at a dose of 35 Gy or 25 Gy, respectively. Free plasma haemoglobin and extracellular potassium levels were measured in each unit over time. Another unit was divided into three parts for lymphocyte studies; one part was not irradiated as a control and the other two received 25 Gy of irradiation via X-ray or gamma irradiation, respectively. RESULTS: Minimally increased free plasma haemoglobin was found only in X-ray-irradiated units after 25 Gy compared to gamma-irradiated units. However, extracellular potassium levels were not significantly different in these groups. Extracellular potassium levels were slightly higher only in gamma irradiated units at 35 Gy. X-ray and gamma irradiation were equivalent in affecting lymphocyte function. CONCLUSIONS: Small differences in RBC membrane permeability are found between gamma-irradiated and X-ray-irradiated units. However, these differences are not likely to be clinically important.
BACKGROUND AND OBJECTIVES: Transfusion-associated graft-versus-host disease (TA-GVHD) is a serious, potential complication of blood transfusion that is essentially prevented by blood product irradiation. Blood product irradiation is currently performed using gamma irradiation. X-ray irradiation is an alternative that has certain advantages: an X-ray irradiator is less expensive and does not have a radioactive source. However, the biochemical effects of X-ray irradiation on red blood cells (RBCs) have not been well characterized. The primary purpose of our study was to compare the effects of X-ray irradiation with gamma irradiation on RBC membrane permeability. A secondary purpose was to verify that X-ray irradiation has the same effect on lymphocytes as gamma irradiation. MATERIALS AND METHODS: Ten RBC units were split into two portions; five units of each were then irradiated with either gamma or X-ray at a dose of 35 Gy or 25 Gy, respectively. Free plasma haemoglobin and extracellular potassium levels were measured in each unit over time. Another unit was divided into three parts for lymphocyte studies; one part was not irradiated as a control and the other two received 25 Gy of irradiation via X-ray or gamma irradiation, respectively. RESULTS: Minimally increased free plasma haemoglobin was found only in X-ray-irradiated units after 25 Gy compared to gamma-irradiated units. However, extracellular potassium levels were not significantly different in these groups. Extracellular potassium levels were slightly higher only in gamma irradiated units at 35 Gy. X-ray and gamma irradiation were equivalent in affecting lymphocyte function. CONCLUSIONS: Small differences in RBC membrane permeability are found between gamma-irradiated and X-ray-irradiated units. However, these differences are not likely to be clinically important.
Authors: Lisa-Marie Schaden; Miriam Wimmer-Teubenbacher; Johannes Poms; Peter Laggner; Karl Lohner; Stephan Sacher; Johannes G Khinast; Sharareh Salar-Behzadi Journal: Pharm Res Date: 2018-05-07 Impact factor: 4.200
Authors: Lourdes Cruz-Garcia; Grainne O'Brien; Ellen Donovan; Lone Gothard; Sue Boyle; Antoine Laval; Isabelle Testard; Lucyna Ponge; Grzegorz Woźniak; Leszek Miszczyk; Serge M Candéias; Elizabeth Ainsbury; Piotr Widlak; Navita Somaiah; Christophe Badie Journal: Health Phys Date: 2018-07 Impact factor: 1.316
Authors: Bobby R Scott; Yong Lin; Bryanna Saxton; Wenshu Chen; Charles A Potter; Steven A Belinsky Journal: Dose Response Date: 2021-05-31 Impact factor: 2.658
Authors: Robert A DeSimone; Colleen Plimier; Catherine Lee; Tamir Kanias; Melissa M Cushing; Bruce S Sachais; Steven Kleinman; Michael P Busch; Nareg H Roubinian Journal: Transfusion Date: 2020-05-01 Impact factor: 3.337
Authors: A Colello Bruno; S J Mazaro; L L Amaral; E M Rego; H F Oliveira; J F Pavoni Journal: Braz J Med Biol Res Date: 2017-03-02 Impact factor: 2.590